InHealth Policy PodcastbyAtlas Point Podcasts·Jan 21Ross Marchand on the 340B Drug Program and the Hidden Costs to Patients and TaxpayersIn this episode of the Health Policy Podcast, Ross Marchand, executive director of the Taxpayers Protection Alliance, examines how the…
Marko Fields·Aug 3, 2023Empowering Communities of Color: The 340B Program and HIV SupportThe 340B Drug Pricing Program is a game-changer in bridging healthcare disparities faced by communities of color, particularly in the…
AIR 340B·Dec 1, 202230 Years of 340B: Policymakers Must Act Now to Prioritize Transparency, Accountability, and…With the 340B program marking its 30th anniversary in November, we must ask: who is benefiting from this drug pricing program? Is it truly…
AIR 340B·Aug 3, 2022AIR340B to FTC: Outsized role of PBMs in safety-net program harms vulnerable patientsFor vulnerable patients across America, getting the 340B Drug Pricing Program right could be the difference between receiving lifesaving…
AIR 340B·May 11, 2021Congress should act on overwhelming support for changes to vital drug discount programBy: Former Congressman Bob Dold, AIR340B Spokesperson
Avalere Health·Mar 31, 2021OPPS 340B Policy Reversal Lowers Hospital Payment and Increases Copays | Avalere HealthAuthored by Joanna Young, Michael Kearney, and Fred Bentley
InChronicledbyMike Hill·Jan 25, 2021The Impact of 340B Restrictions on Pharmaceutical Contract AdministrationIn 2020, multiple pharmaceutical manufacturers announced they would be restricting 340B pricing discounts offered to contract pharmacies…A response icon1A response icon1
AIR 340B·Sep 24, 2018GAO Raises Additional Concerns With 340B Contract Pharmacies and HospitalsThe 340B drug discount program — a vital safety-net program created to help millions of vulnerable or uninsured patients receive care — is…
